Rona M. MacKie - Concepedia

Author

Rona M. MacKie

Also Known As

ATHENS Melanoma Study Group, R M MacKie, RONA M. M. MACKIE, RONA M. MACKIE, RONA M. MacKIE, RONA M. MacKie, RONA M. Mackie, RONA MACKIE, RONA MacKIE, Rona M MacKie

211

Publications

10.6K

Citations

H-Index

122

Concepts

All Affiliations

University of Glasgow Western Infirmary QIMR Berghofer Medical Research Institute Public Health Scotland University of Pennsylvania

About

Rona M. MacKie is an author at University of Glasgow specializing in medicine, dermatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	68	5.9K
2	Allergy	9	9	608
3	Health Sciences	4	4	319
4	Engineering	2	2	62
5	Public Health	1	1	101

Rona M. MacKie

107

Publications

8.6K

Citations

H-Index

Page 1

	Year	Citations
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial Alexander M.M. Eggermont, Stefan Suciu, Mario Santinami, The Lancet Surgical OncologyMedicineEortc 18991MelanomaImmunology	2008	638
Thin Stage I Primary Cutaneous Malignant Melanoma Umberto Veronesi, Natale Cascinelli, Jerzy Adamus, New England Journal of Medicine Surgical OncologyMedicineUndergone Narrow ExcisionMinimally Invasive ProcedureMelanoma	1988	563
Genome-wide association study identifies three loci associated with melanoma risk D. Timothy Bishop, Florence Démenais, Mark M. Iles, Nature Genetics Genome-wide Association StudyCancer RiskGeneticsMelanomaGenetic Epidemiology	2009	457
High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL Alisa M. Goldstein, May Chan, Mark Harland, Cancer Research	2006	414
Sentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program Experience Natale Cascinelli, Filiberto Belli, Mario Santinami, Annals of Surgical Oncology Dermoscopic ImageSurgical PathologyMelanomaCutaneous MelanomaDermatology	2000	332
Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial Alexander M.M. Eggermont, Stefan Suciu, Rona M. MacKie, The Lancet Surgical OncologyOncologyMelanomaImmunologyClinical Trials	2005	310
Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies Judith M. Bliss, Deborah Ford, Anthony J. Swerdlow, International Journal of Cancer	1995	265
Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy Rosemary Lever, KAY HADLEY, D.G. Downey, British Journal of Dermatology AllergyAntibioticsHealth SciencesAtopic DermatitisDouble Blind Placebo	1988	259
Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial Natale Cascinelli, Filiberto Belli, Rona M. MacKie, The Lancet Interferon Alpha-2aSurgical OncologyMedicineRandomised TrialMelanoma	2001	247
Genome-wide association study identifies three new melanoma susceptibility loci Jennifer H. Barrett, Mark M. Iles, Mark Harland, Nature Genetics Genome-wide Association StudyGeneticsMelanomaGenetic EpidemiologyGenomics	2011	245

Page 1